Prenatal screening for trisomy 21 (Down syndrome) using first- and second-trimester biochemistry and nuchal translucency: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
Saved in:
| Title: | Prenatal screening for trisomy 21 (Down syndrome) using first- and second-trimester biochemistry and nuchal translucency: A technical standard of the American College of Medical Genetics and Genomics (ACMG). |
|---|---|
| Authors: | Palomaki GE; Alpert Medical School at Brown University, Providence, RI; Women and Infants Hospital of Rhode Island, Providence, RI., Smith WE; Maine Medical Center, Portland, ME., Bajaj K; NYC Health and Hospitals, New York, NY., Rowsey R; Mayo Clinic, Rochester, MN., Hurst ACE; University of Alabama at Birmingham, Birmingham, AL., Messerlian G; Alpert Medical School at Brown University, Providence, RI; Women and Infants Hospital of Rhode Island, Providence, RI., Best RG; University of South Carolina School of Medicine, Greenville, SC; Labcorp, Clinical Cytogenetics Laboratory, Durham, NC. |
| Corporate Authors: | ACMG Laboratory Quality Assurance Committee. Electronic address: documents@acmg.net; American College of Medical Genetics and Genomics, Bethesda, MD. |
| Source: | Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2025 Sep; Vol. 27 (9), pp. 101505. Date of Electronic Publication: 2025 Aug 06. |
| Publication Type: | Journal Article; Practice Guideline |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1530-0366 |
|---|---|
| DOI: | 10.1016/j.gim.2025.101505 |
